Zing_health Prior Authorization Lookup
Latest Zing_health prior authorization updates25
- Prior AuthClinical/Medical Policy2026 Zing Health Part D Transition Policy StatementThis policy governs temporary prescription supplies and transition options for new and existing Zing Health Medicare Part D members whose current drugs are non-formulary or subject to prior authorization, step therapy, or another restriction, including emergency supplies during long-term-care and other level-of-care transitions.All zing_health updates
- Prior AuthClinical/Medical PolicyContinuous Glucose Monitors (CGM) & Diabetic Testing Supplies Coverage 2025This policy governs Zing Health coverage, prior authorization, preferred products, and member cost sharing for continuous glucose monitors, diabetic testing supplies, and specified insulin delivery devices for members with diabetes, prediabetes, gestational diabetes, or certain medication-related blood glucose risks.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B PD-1/PD-L1 Step Therapy for Basal Cell Carcinoma and Squamous Cell CarcinomaThis policy governs Medicare Part B coverage of specified PD-1/PD-L1 products for members receiving treatment for basal cell carcinoma or squamous cell carcinoma. Libtayo is preferred, while coverage of non-preferred Keytruda requires an applicable clinical exception through prior authorization.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Acromegaly Long Acting ProductsThis policy governs coverage of acromegaly long-acting products under Medicare Part B for Zing Health members. Non-preferred products require a clinical exception through prior authorization based on prior treatment, inadequate response, or an intolerable adverse event involving the preferred product.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Alpha1-Proteinase InhibitorsThis policy governs preferred-product sequencing and prior authorization exceptions for alpha1-proteinase inhibitor products under Medicare Part B. It affects members who are new to treatment with a non-preferred product and requires a clinical exception for non-preferred coverage.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy AntimetabolitesThis policy governs preferred and non-preferred antimetabolite products for Medicare Part B members requesting treatment. Non-preferred products require prior authorization and are covered when specified clinical exception criteria are met.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy AsthmaThis policy governs coverage of preferred and non-preferred asthma biologic products billed under Medicare Part B for Zing Health members. Non-preferred Cinqair and Nucala require clinical exception criteria through prior authorization, while preferred products may still require clinical prior authorization.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Autoimmune ConditionsThis policy governs coverage of specified Medicare Part B autoimmune-condition drug products for Zing Health members. Preferred products are generally used first, while non-preferred products require prior authorization based on prior treatment, clinical intolerance or inadequate response, or other specified clinical exceptions.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Bevacizumab-Oncology ProductsThis policy governs Medicare Part B coverage of preferred and non-preferred bevacizumab-oncology products for Zing Health members. Non-preferred products require a clinical exception through prior authorization, subject to step-therapy criteria and applicable Medicare coverage and utilization-management requirements.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Breast CancerThis policy governs preferred-product selection and prior authorization exceptions for Medicare Part B members requesting specified breast cancer products. It applies the Advanced Biosimilars First step-therapy program, with nonpreferred coverage available when defined clinical exception criteria are met.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Erythropoiesis Stimulating AgentsMedicare Part B coverage of preferred and non-preferred erythropoiesis-stimulating agents, including biosimilar-first preferences and prior authorization exceptions for non-preferred products.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Factor VIII ProductsThis policy governs Medicare Part B coverage and prior authorization for preferred and non-preferred recombinant Factor VIII products under an Advanced Biosimilars First step-therapy program. It applies to members who are new to treatment with a non-preferred product and establishes clinical exception pathways for non-preferred therapy.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Gaucher Disease AgentsThis policy governs Medicare Part B coverage of specified Gaucher disease products under Zing Health's Advanced Biosimilars First step-therapy program. It establishes preferred products and an exception process requiring prior authorization for nonpreferred products, primarily for members new to nonpreferred treatment.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Gonadotropin Releasing Hormone AgonistsMedicare Part B coverage of gonadotropin-releasing hormone agonists for prostate cancer; Eligard is preferred, and non-preferred products require a qualifying clinical exception through prior authorization.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy HyaluronatesCoverage of preferred and non-preferred hyaluronate products for Medicare Part B members receiving FDA-approved osteoarthritis treatment; non-preferred products require prior authorization and a qualifying clinical exception.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Immune GlobulinsThis policy governs coverage of preferred and non-preferred immune globulin products under Medicare Part B Advanced Biosimilars First. Non-preferred products require prior authorization and are covered for new starts when specified clinical exception criteria are met.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy InfliximabThis policy governs coverage of infliximab products under Medicare Part B, including the preferred-product pathway and prior authorization exceptions for non-preferred products.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Intravenous IronThis policy governs coverage of preferred and non-preferred intravenous iron products under Medicare Part B for Zing Health members. Non-preferred products require prior authorization and are covered when specified clinical exception or prior-use criteria are met.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Mitotic InhibitorsThis policy governs coverage of preferred and non-preferred mitotic inhibitor products under Medicare Part B Advanced Biosimilars First. Non-preferred Abraxane requires prior authorization and a clinical exception for treatment of an FDA-approved indication of a preferred product.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Multiple MyelomaThis policy governs Medicare Part B coverage of preferred and non-preferred multiple myeloma products for Zing Health members. Non-preferred products require prior authorization and are covered when specified clinical exception criteria are met.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Multiple SclerosisThis policy governs coverage and prior authorization for preferred and non-preferred multiple sclerosis products administered under Medicare Part B. It applies to members requesting a non-preferred product and provides clinical exception criteria based on prior treatment, inadequate response, adverse events, or contraindications.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Osteoporosis-Bone DensityThis policy governs Medicare Part B coverage of specified osteoporosis products for Zing Health members. It identifies preferred products and establishes a prior authorization exception process for the non-preferred product, in addition to applicable Medicare coverage and utilization management requirements.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy PD1/PDL1 Products - Non-Small Cell Lung Cancer (NSCLC)This policy governs Medicare Part B coverage of specified PD-1/PD-L1 products for non-small cell lung cancer (NSCLC). Libtayo is preferred, while non-preferred products require prior authorization and an approved clinical exception for members new to non-preferred treatment.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Retinal DisordersThis policy governs Medicare Part B coverage of preferred and non-preferred products used for retinal disorders under Zing Health. Non-preferred products require prior authorization and a clinical exception based on prior treatment, inadequate response, intolerable adverse events, or specified diagnoses.All zing_health updates
- Prior AuthClinical/Medical PolicyMedicare Part B Step Therapy Rituximab ProductsThis policy governs preferred-product sequencing and prior authorization exceptions for Zing Health Medicare Part B members requesting rituximab products. Non-preferred products may be covered when specified prior-use or intolerance criteria are met, in addition to applicable Medicare coverage and utilization management requirements.All zing_health updates
Tool Description
Search Zing_healthprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Billing Code Reimbursement RatesBuild a reimbursement rate report across any mix of billing codes and states, comparing commercial payers against Medicare.
- Payer Comparison DashboardPick 2-5 payers to compare market share, premium, and membership by region, all at once.
- Facility Comparison DashboardPick 2-6 hospital facility types (or add a specific hospital) to compare facility count, revenue, net income, and Medicare/Medicaid payer mix by region, all at once.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.